| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/06/2004 | US6759534 Reacting benzofuran derivative with organolithium compound in presence of sulfur source; reacting with dichloropyridazine derivative, reacting with alkaline alkoxide in alkanol; reacting with mineral acid, oxidation |
| 07/06/2004 | US6759518 Single-chain multiple antigen-binding molecule, its preparation and use |
| 07/06/2004 | US6759430 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 07/06/2004 | US6759427 Synthesis and methods of use of tetrahydroindolone analogues and derivatives |
| 07/06/2004 | US6759424 Imidazolidine derivatives, their preparation, their use, and pharmaceutical preparations comprising them |
| 07/06/2004 | US6759422 Administering benzothiazole compound for therapy, prophylaxis of disease |
| 07/06/2004 | US6759421 Indoline compounds, a process for their preparation and pharmaceutical compositions containing them |
| 07/06/2004 | US6759418 6-(((2s)-2-(alkoxycabonyl)-4,4-difluoropyrrolidinyl)methyl)-1, 2, 3.4, 4a, 5, 6, 7, 8, 8a-decahydroisoquinoline-3-carboxylate, or acid derivatives, useful for treating migraine, and dural protein extravasation |
| 07/06/2004 | US6759415 Affinity with subtypes of somatostatin receptors |
| 07/06/2004 | US6759412 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis |
| 07/06/2004 | US6759405 Cycloocta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives |
| 07/06/2004 | US6759404 Inhibiting gamma-secretase activity; treating diseases associated with beta-amyloid production, such as alzheimer's disease |
| 07/06/2004 | US6759402 Cyclic felbamate derived compounds |
| 07/06/2004 | US6759399 Using such as gamma-lactone of 10-ethynyl-17-hydroxy-3-oxo-19-nor-17-pregna-4,9(11)-diene-21-carboxylic acid |
| 07/06/2004 | US6759387 Delivery enhancing transporter that has sufficient guanidino or amidino sidechain moieties to enhance delivery of a compound conjugated to the reagent across one or more layers of the tissue |
| 07/06/2004 | US6759208 Prevention, therapy disease; forming tritiated water; calibration |
| 07/06/2004 | US6759201 Method of identifying a neural progenitor cell by evaluating expression of daedalos |
| 07/06/2004 | US6759194 Nucleotide sequences encoding peroxisome-associated polypeptides, and their uses in the diagnosis and/or treatment of lung injuries and diseases, and of oxidative stress-related disorders |
| 07/06/2004 | US6759059 Fentanyl composition for the treatment of acute pain |
| 07/06/2004 | US6759049 Pharmaceutical or dietetic mushroom-based compositions |
| 07/06/2004 | US6758840 Drug delivery device |
| 07/06/2004 | CA2303594C Compounds for treating and preventing diabetic complications |
| 07/01/2004 | WO2004055211A2 Compositions and methods for detecting and treating neurodegenerative pathologies |
| 07/01/2004 | WO2004055201A2 Cholesterol 24-hydroxylase (cyp46) as therapeutic target for the treatment of alzheimer's disease |
| 07/01/2004 | WO2004055185A1 Novel protein and dna thereof |
| 07/01/2004 | WO2004055055A1 The transmembrane protein amigo and uses thereof |
| 07/01/2004 | WO2004055026A1 Tetracyclic 3-substituted indoles having serotonin receptor affinity |
| 07/01/2004 | WO2004055024A1 3-substituted 3,4-dihydro-thieno[2,3-d]pyrimidine-4-one-derivatives, production and use thereof |
| 07/01/2004 | WO2004055009A1 Novel compounds having selective inhibiting efect at gsk3 |
| 07/01/2004 | WO2004055006A1 Novel compounds having selective inhibiting effect at gsk3 |
| 07/01/2004 | WO2004055005A1 Novel compounds having selective inhibiting effect at gsk3 |
| 07/01/2004 | WO2004054988A1 Arylthioetherpyrimidine and aryloxyetherpyrimidine derivatives and their therapeutic uses |
| 07/01/2004 | WO2004054985A1 3h-quinazolin-4-one derivatives |
| 07/01/2004 | WO2004054981A1 5-aminophenanthridine derivatives as npy-5 antagonists |
| 07/01/2004 | WO2004054979A1 Jnk inhibitors |
| 07/01/2004 | WO2004054957A2 Valproic acid analogues and pharmaceutical compositions thereof |
| 07/01/2004 | WO2004054621A1 Water-soluble clathrates of ziprasidone and its salts, and the preparation methods therefor |
| 07/01/2004 | WO2004054617A1 Preventives and/or remedies for central diseases |
| 07/01/2004 | WO2004054616A1 Antagonist and agonist binding to strong binding site of chemokine receptor |
| 07/01/2004 | WO2004054591A1 The use of compound helicid for manufacturing medicine to treat depresion and/or disorders caused by depresion |
| 07/01/2004 | WO2004054587A1 Treatment of neuro-psychiatric disorders |
| 07/01/2004 | WO2004054582A1 Combination therapy for the treatment of pain |
| 07/01/2004 | WO2004054579A1 2-pyridyl and 2-pyrimidyl cycloalkylene amide compounds as nr2b receptor antagonists |
| 07/01/2004 | WO2004054578A1 Treatment of psychostimulant addiction |
| 07/01/2004 | WO2004054577A1 Alpha-2-delta ligands to treat ocd and related diseases |
| 07/01/2004 | WO2004054570A1 Combinations of medicaments comprising an alcohol deterrent for treating alcohol dependence or alcohol abuse |
| 07/01/2004 | WO2004054567A1 Use of carnitines for the prevention and/or treatment of disorders caused by the andropause |
| 07/01/2004 | WO2004054566A1 Pregabalin derivatives for the treatment of fibromyalgia and other disorders |
| 07/01/2004 | WO2004054565A1 Pregabalin and derivates thereof for the treatment of fibromyalgia and other related disorders |
| 07/01/2004 | WO2004054564A1 Gabapentin analogues for fibromyalgia and other related disorders |
| 07/01/2004 | WO2004054563A1 Alpha-2-delta ligand for the treatment of sexual dysfunction |
| 07/01/2004 | WO2004054559A1 Alpha2delta ligands for different pharmaceutical uses |
| 07/01/2004 | WO2004054550A1 An extended release pharmaceutical composition of phenytoin sodium |
| 07/01/2004 | WO2004039385A3 Mucuna pruriens and extracts thereof for the treatment of neurological diseases |
| 07/01/2004 | WO2004033426A3 Heteroaryl propyl-piperazines and heteroaryl propyl-piperidines serving as dopaminergic and serotoninergic agents |
| 07/01/2004 | WO2004026819A3 OPIATE ANALOGS SELECTIVE FOR THE delta-OPIOID RECEPTOR |
| 07/01/2004 | WO2004022564A3 Alternative processes for the preparation of d- (+) -morphine, and d- (+) - morphine tartrate |
| 07/01/2004 | WO2004022540A3 Pyridazinone and pyridone derivatives as adenosine antagonists |
| 07/01/2004 | WO2004017906A3 Modulation of matrix metalloproteinase (mmp) activity with aldosterone blocker(s) |
| 07/01/2004 | WO2004016612A3 New purine derivatives |
| 07/01/2004 | WO2004014357A3 Therapeutic use of aryl amino acid derivatives |
| 07/01/2004 | WO2004002420A3 Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use |
| 07/01/2004 | WO2003103608A3 Neuroprotective synergy of erythropoietin and insulin-like growth factor |
| 07/01/2004 | WO2003100435A3 Diagnostics and therapeutic use of neuromedin u receptor 2 (nmu2) |
| 07/01/2004 | WO2003092716A3 Therapeutic use of pacap, maxadilan, pacap receptor agonist and/or adcyap1r1 in the treatment of cns disorders |
| 07/01/2004 | WO2003092605A3 Protease inhibitors |
| 07/01/2004 | WO2003086325A3 Cyanamides useful as reversible inhibitors of cysteine proteases |
| 07/01/2004 | WO2003080569A3 Egfr ligands and methods of use |
| 07/01/2004 | WO2003053445A8 Use of desoxypeganine for treating clinical depression |
| 07/01/2004 | WO2003045369A9 Use of l isomers of amino acid derivatives of hydroxyguanidine for producing no, pharmaceutical compositions containing same and pharmaceutical uses |
| 07/01/2004 | WO2003040366A3 Inhibitor oligonucleotides and their use for specific repression of a gene |
| 07/01/2004 | WO2003012045A3 Hybrid proteins with neuregulin heparin-binding domain for targeting to heparan sulfate proteoglycans |
| 07/01/2004 | WO2002100341A3 Compounds for the treatment of metabolic disorders |
| 07/01/2004 | WO2002015846A3 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders |
| 07/01/2004 | US20040127712 Aminoalkyl-3, 4-dihydroquinoline derivatives as no-synthase inhibitors |
| 07/01/2004 | US20040127707 Novel phthalazinones |
| 07/01/2004 | US20040127696 Growth differentiation factor-7 |
| 07/01/2004 | US20040127576 Estrogen receptor modulators |
| 07/01/2004 | US20040127572 the prevention or amelioration of sleep-related breathing disorders such as sleep apnea |
| 07/01/2004 | US20040127555 bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs; treatment of A beta , IAPP, other amyloids, and alpha -synuclein or NAC fibrillogenesis |
| 07/01/2004 | US20040127552 Benzoaxathiepin derivatives and their use as medicines |
| 07/01/2004 | US20040127546 for treating or preventing diabetes, obesity, hyperlipidemia, digestive diseases, depression or urinary disturbances; beta 3-agonist |
| 07/01/2004 | US20040127544 Mannich base prodrugs of 3-(Pyrrol-2-yl-methylidene)-2-indolinone derivatives |
| 07/01/2004 | US20040127543 Antidepressant cycloalkylamine derivatives of 2,3-dihydro-1,4-benzodioxan |
| 07/01/2004 | US20040127542 1-(Pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 07/01/2004 | US20040127541 Bicifadine formulation |
| 07/01/2004 | US20040127538 having an excellent JNK inhibitory action |
| 07/01/2004 | US20040127537 Stable liquid parenteral parecoxib formulation |
| 07/01/2004 | US20040127533 Sulfonamide derivatives |
| 07/01/2004 | US20040127528 Metalloproteinase inhibitors |
| 07/01/2004 | US20040127517 For therapy of treat atherosclerosis, autoimmune diseases, multiple sclerosis), asthma, rheumatoid arthritis, fibrotic diseases, idiopathic pulmonary fibrosis, cystic fibrosis, glumerulonephritis, rheumatoid spondylitis, osteoarthritis, gout |
| 07/01/2004 | US20040127516 Substituted dimethyl-[1-(1-phenyl-cyclohexyl)-piperidin-3-ylmethyl]-amines and the use of the same as analgesics |
| 07/01/2004 | US20040127508 Substituted pyrazolopyrimidines and thiazolopyrimidines |
| 07/01/2004 | US20040127505 Administering 1-alkyl-cyclohexanecarboxylic acid {(1R)-1-cyclohexylmethyl-2-[4-(2-methoxyphenyl)-piperazin-1-yl]-ethyl}-amide for potentiating the action of an inhibitor of serotonin reuptake |
| 07/01/2004 | US20040127501 Therapeutic agents useful for treating pain |
| 07/01/2004 | US20040127496 Imidazole-2-carboxamide derivatives as raf kinase inhibitors |
| 07/01/2004 | US20040127494 Sulfur compounds such as (2R)-2-[N-(4-Chlorobenzenesulfonyl)-N-(4-methoxybenzyl)amino]-4-methylpentanoic acid amide, used for prophylaxis of neurodegenarative disorders such as Alzheimer's Disease and Down's Syndrome |
| 07/01/2004 | US20040127493 Antidepressant azaheterocyclylmethyl derivatives of 4,5-dihydroimidazo[1,4,5-de ][1,4]benzoxazine |
| 07/01/2004 | US20040127492 Cyclic pyrazoles for the inhibition of mitogen activated protein kinase-activated protein kinase-2 |
| 07/01/2004 | US20040127490 Administering a therapeutic amount of an alprazolam, estazolam, midazolam or triazolam condensation aerosol for therapy of anxiety or insomnia |